Anti-transforming growth factor-β1 antibody improves survival rate following partial hepatectomy in cirrhotic rats

Hepatology Research

Volumn 24, Issue 2, 2002, Pages 174-183

  Ohara, Kazunori ^a   Kusano, Mitsuo ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Dimethylnitrosamine (DMN); Hyperbilirubinemia; Liver regeneration; MIB 5; TGF 1 mRNA; Transforming growth factor 1 (TGF 1)

Indexed keywords

BUFFER; DIMETHYLNITROSAMINE; DNA; MESSENGER RNA; NEUTRALIZING ANTIBODY; PHOSPHATE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; HYPERBILIRUBINEMIA; LIVER CELL; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FIBROSIS; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; ORGAN WEIGHT; OSMOTIC PUMP; PARTIAL HEPATECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RAT; SURVIVAL RATE; TISSUE REGENERATION;

EID: 0036787210     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(02)00031-1     Document Type: Article

References (39)

1. Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration and other biological functions. Crit Rev Oncog 1992;3:27-54.
2. Rubin JS, Bottaro DP, Aaronson SA. Hepatocyte growth factor/scatter factor and its receptor, the c-met protooncogene product. Biochim Biophys Acta 1993;1155:357-71.
3. Fujiwara K, Nagoshi S, Ohno A, et al. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 1993;18:1443-9.
4. Shiota G, Wang TC, Nakamura T, et al. Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression. Hepatology 1994;19:962-72.
5. Sakata H, Takayama H, Sharp R, et al. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ 1996;7:1513-23.
6. Ishii T, Sato M, Sudo K, et al. Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats. J Biochem Tokyo 1995;117:1105-12.
7. Ishiki Y, Ohnishi H, Muto Y, et al. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent anti-hepatitis effect in vivo. Hepatology 1992;16:1227-53.
8. 4-induced acute liver injury in rats. Biochem Biophys Res Commun 1996;218:1-5.
9. Kaido T, Yamaoka S, Seto S, et al. Continuous hepatocyte growth factor supply prevents lipopolysaccharide-induced liver injury in rats. FEBS Lett 1997;411:378-82.
10. Matsuda Y, Matsumoto K, Ichida T, et al. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem Tokyo 1995;118:643-9.
11. Yasuda H, Imai E, Shiota A, et al. Antifibrotic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 1996;24:636-42.
12. Moses HL, Braun EL, Proper JA, et al. Transforming growth factor production by chemically transformed cells. Cancer Res 1981;41:2842-8.
13. Roberts AB, Anzano MA, Lamb LC, et al. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci USA 1981;78:5339-43.
14. Tucker RF, Shipley GD, Moses HL, et al. Growth inhibitor form BSC-1 cells closely related to platelet type β transforming growth factor. Science 1984;226:705-7.
15. Moses HL, Tucker RF, Leof EG, et al. Type-β transforming growth factor is a growth stimulator and a growth inhibitor. Cancer Cells 1985;3:65-71.
16. Carr BI, Hayashi I, Braun EL, et al. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor. Cancer Res 1986;46:2330-4.
17. Nakamura T, Tomita Y, Hirai R, et al. Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun 1985;133:1042-50.
18. McMahon JB, Richards WL, del Campo AA, et al. Differential effects of transforming growth factor-β on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res 1986;46:4665-71.
19. Russell WE, Coffey RJ Jr, Quellette AJ, et al. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 1988;85:5126-30.
20. Braun L, Mead JE, Panzica M, et al. Transforming growth factor β mRNA increases during liver regeneration: a possible paracrine mechanism of growth reguration. Proc Natl Acad Sci USA 1988;85:1539-43.
21. Czaja MJ, Weiner FR, Flanders KC, et al. In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell Biol 1989;108:2477-82.
22. Kaido T, Yoshikawa A, Seto S, et al. Portal branch ligation with a continuous hepatocyte growth factor supply makes extensive hepatectomy possible in cirrhotic rats. Hepatology 1998;28:756-60.
23. 4 treatment. Lab Invest 1993;69:283-94.
24. Jenkins SA, Grandison A, Baxter JN, et al. A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat. J Hepatol 1985;1:489-99.
25. Jezequel AM, Mancini R, Rinaldesi ML, et al. A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat. J Hepatol 1987;5:174-81.
26. Higgins GM, Anderson RM. Experimental pathology of liver: restoration of liver of the white rat following partial surgical removal. Arch Pathol 1931;12:186-202.
27. Roberts AB, Joyce ME, Bolander ME, et al. Transforming growth factor-β (TGF-β): a multifunctional effector of both soft and hard tissue regeneration. In: Westermark B, Betsholtz C, Hökfelt B, et al., editors. Growth factors in health and disease: basic and clinical aspects. Amsterdam: Excepta Medica, 1990:89-101.
28. Wahl SM, Hunt DA, Wakefield LM, et al. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987;84:5788-92.
29. Postlethwaite AE, Keski-Oja J, Moses HL, et al. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β. J Exp Med 1987;165:251-6.
30. Kim SJ, Angel P, Lafyatis R, et al. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol Cell Biol 1990;10:1492-7.
31. Mitsue S, Hamanoue M, Tnanabe G, et al. Expression of HGF and TGF-β1 mRNA after partial hepatectomy in rats with liver cirrhosis. Surg Today 1995;25:237-43.
32. Carr BI, Hayashi I, Branum EL, et al. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor. Cancer Res 1986;46:2330-4.
33. Sanchez A, Alverz AM, Benito M, et al. Apoptosis induced by transforming growth factor-β in fetal hepatocyte primary cultures. J Biol Chem 1996;271:7416-22.
34. Hirata K, Ogata I, Ohta Y, et al. Hepatic sinusoidal cell destruction in the development of intravascular coagulation in acute liver failure of rats. J Pathol 1989;158:157-65.
35. Friedman SL. The cellular basis of hepatic fibrosis. New Engl J Med 1993;328:1828-35.
36. Nakamura T, Sakata R, Ueno T, et al. Inhibition of transforming growth factor β revents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 2000;32:247-55.
37. Mavier P, Mallet A. Perspectives in the treatment of liver fibrosis. J Hepatol 1995;22(Suppl. 2):111-5.
38. Strobel D, Wittekind C, Ruoslahti E, et al. In vivo application of a neutralizing TGF-β antibody in experimental liver fibrosis. J Hepatol 1993;18(Suppl. 1):S63.
39. George J, Ramesh Rao K, Stern R, et al. Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen. Toxicology 2001;156:129-38.